| abstract |
The present invention provides novel substituted 1 H -Pyrrolopyridinone derivatives of formula (1) as protein kinase inhibitors, in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and 'p' have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting kinase enzyme, more particularly BTK enzyme. The present invention also provides methods for synthesizing and administering the kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. |